Progyny, Inc.

PGNY · Healthcare

$25.66

Capitalizzazione: 1.97B USDRendimento da dividendo: —
AdvanceÈ un buon momento per comprare Progyny, Inc.? Chiedi a Copenvest AIOttieni un'analisi Advance con AI su timing, rischio e cosa fanno gli investitori tracciati.Chiedi a Copenvest AI

Caricamento grafico…

Notizie

Ultime notizie su questo titolo

GlobeNewswire Inc.7 ago 2026, 14:51

Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference

Progyny, Inc. (Nasdaq: PGNY), a women's health and family building solutions company, announced that CEO Pete Anevski will present at the Canaccord Genuity 46th Annual Growth Conference in Boston on August 11, 2026. The company recently reported record quarterly revenue, gross profit, and adjusted EBITDA for Q2 2026, with strong demand continuing for its women's health and family building solutions.